A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Axogen, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 23,202 shares of AXGN stock, worth $326,452. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,202
Previous 21,151 9.7%
Holding current value
$326,452
Previous $153,000 112.42%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.52 - $14.69 $15,423 - $30,129
2,051 Added 9.7%
23,202 $325,000
Q2 2024

Aug 14, 2024

BUY
$5.67 - $8.06 $119,926 - $170,477
21,151 New
21,151 $153,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $595M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.